SCHEMBL6510002

SCHEMBL6510002

COC(=O)C(CC(C)C)Nc1cc(Nc2cccc(F)c2)cc(Sc2ccc(OC)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSK P43235 6/20 0.43
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
CTSL P07711 2/20 0.37
CTSS P25774 2/20 0.37
AURKB Q96GD4 1/20 0.37
PTGIR P43119 1/20 0.37
HPGD P15428 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509993 1.00 CTSK (0.43) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6513754 0.87 ALDH1A1 (0.39) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6513221 0.87 CTSK (0.40) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6513215 0.87 CTSK (0.40) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6513761 0.87 ALDH1A1 (0.39) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6510466 0.86 ALDH1A1 (0.40) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6510461 0.86 ALDH1A1 (0.40) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6532032 0.85 CYP1A2 (0.39) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6530218 0.84 CTSK (0.38) CTSKALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6512117 0.83 CTSK (0.38) CTSKALDH1A1CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed